1. Home
  2. CVGI vs SNTI Comparison

CVGI vs SNTI Comparison

Compare CVGI & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Commercial Vehicle Group Inc.

CVGI

Commercial Vehicle Group Inc.

HOLD

Current Price

$1.56

Market Cap

50.7M

ML Signal

HOLD

Logo Senti Biosciences Inc.

SNTI

Senti Biosciences Inc.

HOLD

Current Price

$1.24

Market Cap

53.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CVGI
SNTI
Founded
2000
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.7M
53.6M
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
CVGI
SNTI
Price
$1.56
$1.24
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$9.00
AVG Volume (30 Days)
92.6K
4.1M
Earning Date
11-10-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$657,532,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.32
$150.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.81
$1.26
52 Week High
$2.59
$5.96

Technical Indicators

Market Signals
Indicator
CVGI
SNTI
Relative Strength Index (RSI) 44.21 33.35
Support Level $1.52 $1.34
Resistance Level $1.67 $2.88
Average True Range (ATR) 0.09 0.24
MACD -0.01 -0.10
Stochastic Oscillator 16.07 0.30

Price Performance

Historical Comparison
CVGI
SNTI

About CVGI Commercial Vehicle Group Inc.

Commercial Vehicle Group Inc is a provider of systems, assemblies, and components to the commercial vehicle market and the electric vehicle markets. It delivers solutions to complex design, engineering, and manufacturing problems while creating positive change for customers, industries, and communities. Its operating segments are Vehicle Solutions, Electrical Systems, and Aftermarket and Accessories. The company makes the majority of its revenue from Vehicle Solutions. The group generates revenue from its products including seating systems, plastic components, electrical wire harnesses, mirrors, wipers, and other accessories. Its geographic regions are North America, Europe and Asia-Pacific.

About SNTI Senti Biosciences Inc.

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

Share on Social Networks: